# Pfizer Inc. (PFE) — Q1-2012 Earnings Results

**Report date:** 2012-05-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q1-2012

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 0.52%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | +3.20% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management acknowledged the competitive landscape and its impact on performance. They reiterated their commitment to long-term growth through new product development.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.52%. This could suggest investor concerns about future revenue growth or broader market conditions despite the EPS beat.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q1-2012_